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Abstract: A 39-year-old woman was diagnosed with myasthenia gravis when she was 8 years 
old. Although many treatments – such as cholinesterase inhibitors and steroids – had been given 
to the patient, her condition did not improve sufficiently. As she demonstrated bilateral 3 mm 
levator function without any eye movement disturbances, bilateral frontalis sling procedures 
were performed with an autologous fascia lata. One year after the operation, the operated upper 
eyelids showed symmetrically appropriate heights with good functional outcome. A sling 
  procedure with an autologous fascia lata was suitable for correcting poor levator function of 
an ocular myasthenia gravis case.
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Introduction
Myasthenia gravis (MG), an autoimmune disease, impedes the postsynaptic 
  acetylcholine receptors at the neuromuscular junction.1 Ocular MG is a   representative 
manifestation of this entity in which blepharoptosis and/or eye movement   disturbances 
are often encountered.2 In general, up to 85% of all myasthenic patients show the 
  anticholinesterase receptor antibody in serum, but only about 50% of patients 
  demonstrate ocular muscle weakness.3 Although cholinesterase inhibitors with or 
without steroids are commonly used as a treatment modality, they are, occasionally, 
less effective for ocular symptoms.4 In such a case, especially for ptosis without any eye 
movement disorders, ptosis surgery is often performed. This paper presents an ocular 
MG case with eyelid dysfunction, in which cholinesterase inhibitors and steroids did 
not work sufficiently, but surgical treatment successfully improved the symptom.
Case report
A 39-year-old woman was diagnosed with MG when she was 8 years old. With a 
positive edrophonium test and detectable serum acetylcholine receptor antibody, 
the diagnosis of ocular MG was confirmed in addition to the unresponsiveness to 
treatment with pyridostigmine and steroids at 31 years of age. Despite long-term 
treatment with steroids, she had difficulty opening both eyes, which caused stiff 
shoulders and headaches. She was then referred to the authors’ clinic for possible 
surgical management.
As she showed bilateral 3 mm levator function (Figure 1A) without any eye 
movement disturbances, bilateral frontalis sling procedures were performed with an 
autologous fascia lata. The skin incision was made 6 mm from the eyelid margin, 
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Figure 1 (A) Preoperative view of the patient with ptosis shows that she has a 
prominent wrinkle in her forehead and sticks out her chin when she tries to open 
her eyes. (B) Postoperative view shows that the eyelids are symmetrical and in the 
appropriate position 1 year after the operation.
Figure 2 (A) Marking of the incisions before the procedure. The skin incision was 
made 6 mm from the eyelids margin, and the central area of the upper brow margin 
was also incised. (B) A view of the skin incisions before closure. With autologous 
fascia lata, bilateral frontalis slings were performed.
and the central area of the upper brow margin was also 
incised (Figure 2A). A tunnel was made from the brow 
incision through the suborbicularis oculi layer, and reached 
the   pretarsal area. The branched fascia lata was sutured with 
6–0 nylon (Sigma, Tokyo, Japan) on the tarsal plate and then 
the upper eyelid curvature was confirmed by pulling the fascia 
through the suborbicularis tunnel (Figure 2B). After the upper 
eyelid height was adjusted appropriately with a trial suture 
at the brow incision, the fascia was fixed at the subcutaneous 
tissue of the brow.
One year after the operation, the upper eyelids showed 
symmetrically appropriate heights (Figure 1B). The patient 
did not demonstrate exposure keratitis, wound infection, 
lagophthalmos, or ptosis in the 6 months following the 
operation.
Discussion
The frontalis sling surgery for ptosis by ocular MG 
  accomplished functionally and cosmetically good outcomes. 
As the levator function of the patient was bilaterally 3 mm, 
the frontalis sling technique was chosen. In general, ptosis 
with less than 4 mm levator function needs a sling procedure,5 
but with more levator function, levator advancement surgery 
is applied.6 As an excessive advancement of levator often 
leads to an eyelid-eyeball dissociation, causing dry eyes, 
a sling procedure should be used in such a case. In the past, 
numerous materials have been used for slings like silicone 
rods, GORE-TEX®, and autologous tissue graft.5,7–9 The 
autologous graft from fascia lata was chosen rather than the 
artificial material in terms of its histocompatibility.
Although the patient did not show any eye movement 
disturbances, MG patients often show eye   movement 
  disturbances simultaneously with ptosis.10 Bilateral   ptosis 
surgery should be avoided in such a case to prevent 
  postoperative diplopia. In this situation, ptosis surgery should 
only be applied to one side.
Many treatment modalities had been given to the patient, 
but her condition did not show definite   improvement. 
  Generally in MG, anticholinesterases (cholinesterase 
  inhibitors) have limited efficacy. Although steroids are of 
great short-term benefit in most patients with ocular MG, the 
side effects associated with steroids may prevent long-term 
use.10 Therapeutic effect of thymectomy is controversial for 
ocular MG. Therefore, a patient refractory to any medical 
treatments is a good candidate for ptosis surgery.
In conclusion, this paper reports an ocular MG case with 
eyelid dysfunction, in which cholinesterase inhibitors and 
steroids did not work sufficiently, but surgical treatment 
successfully improved the symptom. A sling procedure with 
an autologous fascia was suitable for correcting poor levator 
function of an ocular MG case.
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